doi.org/10.2337/diacare.26.2.427, hdl.handle.net/1765/55736
Diabetes Care
Erasmus MC: University Medical Center Rotterdam

Berk-Planken, I., Hoogerbrugge, N., Stolk, R., Bootsma, A., & Jansen, H. (2003). Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: Effect of sex and the LIPC promoter variant. Diabetes Care, 26(2), 427–432. doi:10.2337/diacare.26.2.427